Cite
HARVARD Citation
Zhao, C. et al. (2019). Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trial. Annals of oncology. pp. 637-643. [Online].